InMode (INMD) FCF Margin Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn | -126.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126.00 |
| Dec 31, 2025 | -2,069.00 |
| Sep 30, 2025 | -1,152.00 |
| Jun 30, 2025 | -1,646.00 |
| Mar 31, 2025 | -1,928.00 |
| Dec 31, 2024 | -1,462.00 |
| Sep 30, 2024 | -2,766.00 |
| Jun 30, 2024 | -499.00 |
| Mar 31, 2024 | -787.00 |
| Dec 31, 2023 | -710.00 |
| Sep 30, 2023 | -1,695.00 |
| Jun 30, 2023 | 3,405.00 |
| Mar 31, 2023 | 485.00 |
| Dec 31, 2022 | -1,567.00 |
| Sep 30, 2022 | 401.00 |
| Jun 30, 2022 | -604.00 |
| Mar 31, 2022 | 2,711.00 |
| Dec 31, 2021 | 1,484.00 |
| Sep 30, 2021 | 2,511.00 |
| Jun 30, 2021 | 216.00 |